Search results for "28"

showing 10 items of 3583 documents

Helicobacter pylori Infection and Risk Factors in Relation to Allergy in Children

2017

Purpose To analyze presence of Helicobacter pylori infection and environmental risk factors among children with and without allergy. Methods Parents of children at primary health care centres/kindergartens and allergologist consultation were asked to answer a questionnaire and to bring a faecal sample. H. pylori infection was detected by monoclonal stool antigen test. Prevalence of H. pylori infection and risk factors were compared between individuals with and without allergy using χ2 test, ANOVA test and parameters and logistic regression. Results Among 220 children (mean age, 4.7 years; ±standard deviation 2.3 years) H. pylori positivity was non-significantly lower among patients with all…

medicine.medical_specialtyAllergyAllergymedicine.medical_treatmentLogistic regression03 medical and health sciences0302 clinical medicineInternal medicineMedicineCaesarean section030212 general & internal medicineFamily historyHepatologybiologyHelicobacter pyloribusiness.industryGastroenterologyOdds ratioHelicobacter pylorimedicine.diseasebiology.organism_classificationConfidence interval030228 respiratory systemRisk factorsPediatrics Perinatology and Child HealthOriginal ArticlebusinessBreast feedingPediatric Gastroenterology, Hepatology & Nutrition
researchProduct

Feasibility of the Allergy Questionnaire for Athletes (AQUA © ) in pediatric age

2018

A burden of respiratory and allergic symptoms up to almost 60% has been observed in young and adult athletes, influencing physical performances1 . The Allergy Questionnaire for Athletes (AQUA©) is a validated screening tool for the prediction of the atopic status in adult athletes2 ; it was recently tested in Belgian young elite athletes (12-14 years old)3 , but its actual feasibility and suitability for children and adolescent was not evaluated. Indeed, there is evidence that children are prone to employ "satisficing" response strategies, answering every question positively/negatively, or simply not answering4 . Therefore, the present cross-sectional survey was carried out to assess feasib…

medicine.medical_specialtyAllergyCross-sectional studyself-reports.ImmunologyMEDLINEAtopy03 medical and health sciences0302 clinical medicinemedicineImmunology and Allergy030212 general & internal medicineAsthmayoung athletesSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' SportivebiologyAthletesbusiness.industrySettore MED/09 - MEDICINA INTERNAAQUA© questionnaireAdolescent; Athletes; Child; Cross-Sectional Studies; Feasibility Studies; Female; Humans; Hypersensitivity; Male; Sports; Surveys and Questionnaires; Pediatrics Perinatology and Child Health; Immunology and Allergy; ImmunologyPediatric ageself-reportsmedicine.diseasebiology.organism_classification030228 respiratory systemFamily medicinePediatrics Perinatology and Child Healthallergy symptoms AQUA© questionnaire feasibility linguistic adaptation young athletes missing answers self-reports.businessSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' Motorieallergy symptomsfeasibilityPediatric Allergy and Immunology
researchProduct

Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SA…

2021

The main contraindication to the anti-SARS CoV2 vaccine is an anaphylactic reaction to a vaccine component. The need to vaccinate allergic people who are at higher risk can be of public health interest and this report shows a case of an allergic reaction to PEG of a HCW who had received the first dose of anti-SARS CoV2 vaccine. For 5 h after the administration of the vaccine, she had the appearance of erythematous spots on the face and neck, and a feeling of a slurred mouth and hoarseness. In order to treat the event, she was administered 8 mg intravenous dexamethasone, 1 vial intravenous chlorphenamine maleate, 250 mL intravenous 0.9% NaCl, and conventional oxygen therapy (2 L/min) with co…

medicine.medical_specialtyAllergyImmunologyadverse reactionCase ReportVial03 medical and health sciences0302 clinical medicineInternal medicinevaccineDrug DiscoverymedicineanaphylaxisPharmacology (medical)030212 general & internal medicineAdverse effectContraindicationDexamethasonePharmacologym-RNA vaccinebusiness.industrySARS CoV2Rmedicine.diseasePEGAdverse reaction Anaphylaxis Basophil activation test Contraindica-tion M-RNA vaccine PEG SARS CoV2 VaccineVaccinationInfectious Diseases030228 respiratory systembasophil activation testMedicinebusinessAnaphylaxisAdverse drug reactioncontraindicationmedicine.drugVaccines
researchProduct

The geriatric asthma: pitfalls and challenges

2016

Historically, asthma has been envisioned as a disease of younger ages. This has led to the assumption that respiratory symptoms suggestive of asthma occurring in older ages are to be attributed to conditions other than asthma, mainly COPD. Old observational reports and new epidemiological studies confirm that asthma is as frequent in older as it is in younger populations. Nevertheless, under-recognition, misdiagnosis and under-treatment are still relevant issues. The characterization of asthma in the aged suffers from the fact that there has been very little original research in this field. Indeed, geriatric asthma is often excluded from clinical trials because of age and comorbidities. The…

medicine.medical_specialtyAllergyReviewDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioBiochemistryComorbiditiesPulmonary function testing03 medical and health sciences0302 clinical medicineimmune system diseasesEpidemiologymedicineAirflow obstructionaged asthma lung function comorbiditiesSenile lung030212 general & internal medicineIntensive care medicineAsthmaCOPDbusiness.industryOrganic Chemistrymedicine.diseaserespiratory tract diseasesClinical trial030228 respiratory systemLung function testsObservational studybusinessGeriatric asthmaAsthma Research and Practice
researchProduct

Fractional exhaled nitric oxide is associated with more severe asthma

2018

Fractional exhaled nitric oxide (FeNO) levels are used as a marker of airway inflammation. The aim of the present work was to evaluate a possible relationship between FeNO and parameters of asthma control and severity in different asthma phenotypes. FeNO was evaluated in 200 asthma patients (37% male, mean age ± SD 54±15 years, 19% controlled (GINA), 30% treated with oral corticosteroids (OCS), median FEV1 (interquartile range) 2,05 L (1,49-2,70), 74% pred. (56-90%)), together with other asthma characteristics (lung function, asthma control, allergies, serum IgE, serum ECP, and blood eosinophils). Patients with poorly controlled asthma had significantly higher FeNO values (ACQ-5≥1.5 vs. 70%…

medicine.medical_specialtyAllergybiologybusiness.industrySevere asthmaAirway inflammationrespiratory systemImmunoglobulin Emedicine.diseaseGastroenterologySerum igerespiratory tract diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineExhaled nitric oxidemedicinebiology.protein030212 general & internal medicinebusinessAsthmaMonitoring Airway Disease
researchProduct

Patógenos atípicos en pacientes hospitalizados con neumonía adquirida en la comunidad: una perspectiva mundial

2018

Abstract Background Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Ris…

medicine.medical_specialtyAtypical pathogensEpidemiologyPopulationSettore MED/10 - Malattie Dell'Apparato Respiratoriolcsh:Infectious and parasitic diseases03 medical and health sciences0302 clinical medicineMedical microbiologyCommunity-acquired pneumoniaInternal medicineEpidemiologyRisk Factors.Medicinelcsh:RC109-216030212 general & internal medicineeducationAged 80 and overeducation.field_of_studybusiness.industryIncidence (epidemiology)Atypical pathogenHealthcare-Associated PneumoniaChlamydophila pneumoniaemedicine.diseaseAntibiotic coverageCAPPneumoniaInfectious Diseases030228 respiratory systemLegionnaires' diseasebusinessResearch Article
researchProduct

Epidemiología de la transfusión sanguínea en los Servicios de Medicina Intensiva en España: «Transfusion Day»

2022

Objective To describe the transfusion practice in the ICUs in Spain, according to national and international recommendations (guidelines).DesignProspective, cross-sectional, multi-centre study.ScopeData collection was carried out by means of a questionnaire sent electronically to the Heads of Service of 111 ICUs in Spain.Participants1,448 patients were included, aged 61.8 (SD 15.7) years, 66.2% male, with an SOFA of 4.7 ± 3.8 and average stay of 10.62 ± 17.49 days.VariablesDemographic and clinical variables of the patients were collected, as well as variables related to the transfusion act.ResultsOf the 1,448 patients, 9.9% received al least one transfusion of any blood product, 3.7% fresh …

medicine.medical_specialtyBlood transfusionbusiness.industryAnemiamedicine.medical_treatmentHemodynamics030208 emergency & critical care medicineCritical Care and Intensive Care Medicinemedicine.disease03 medical and health sciencesRed blood cell0302 clinical medicinemedicine.anatomical_structure030228 respiratory systemBlood productInternal medicineEpidemiologyMedicinePlateletHemoglobinbusinessMedicina Intensiva
researchProduct

Hereditary angioedema: an update on causes, manifestations and treatment.

2019

Hereditary angioedema is a rare genetic disorder caused by deficiency of C1 esterase inhibitor (C1-INH) and characterized by recurrent episodes of severe swelling that affect the limbs, face, intestinal tract and airway. Since laryngeal oedema can be life-threatening as a result of asphyxiation, correct diagnosis and management of hereditary angioedema is vital. Hereditary angioedema attacks are mediated by bradykinin, the production of which is regulated by C1-INH. Hereditary angioedema therapy relies on treatment of acute attacks, and short- and long-term prophylaxis. Acute treatment options include C1-INH concentrate, icatibant and ecallantide. Self-administration of treatment is recomm…

medicine.medical_specialtyBradykinin03 medical and health sciences0302 clinical medicineimmune system diseasesmedicineHumanscardiovascular diseases030212 general & internal medicineskin and connective tissue diseasesHereditary Angioedema Types I and IIbusiness.industryGenetic disorderfood and beveragesGeneral Medicinemedicine.diseaseDermatologyC1 esterase030228 respiratory systemHereditary angioedemaFactor XIIDisease ProgressionQuality of LifeKallikreinsbusinessPeptidesComplement C1 Inhibitor ProteinBritish journal of hospital medicine (London, England : 2005)
researchProduct

Primary ciliary dyskinesia in adults with bronchiectasis: Data from the Embarc registry

2018

Introduction: Primary ciliary dyskinesia (PCD) is an inherited cause of bronchiectasis where defects in motile cilia result in failure to clear mucus. Individuals have life-long productive cough and recurrent infections Methods: The embarc registry is a prospective pan-European observational study of adults with bronchiectasis. Data entered into the registry between March 2015 and Jan 2018 was assessed. Disease severity in PCD was compared to two age and gender matched cohorts, the first consisting of individuals with immune deficiency and a second with idiopathic disease. Results: 287/11204 individuals (2.6%) were reported to have PCD. 65% were female, reflecting the female predominance in…

medicine.medical_specialtyBronchiectasisbusiness.industryIncidence (epidemiology)Diseasemedicine.disease03 medical and health sciences0302 clinical medicineImmune system030228 respiratory systemInternal medicineCohortotorhinolaryngologic diseasesMotile ciliumMedicineSputum030212 general & internal medicinemedicine.symptombusinessPrimary ciliary dyskinesiaRespiratory infections
researchProduct

<p>Day and Night Control of COPD and Role of Pharmacotherapy: A Review</p>

2020

The topic of 24-hour management of COPD is related to day-to-night symptoms management, specific follow-up and patients' adherence to therapy. COPD symptoms strongly vary during day and night, being worse in the night and early morning. This variability is not always adequately considered in the trials. Night-time symptoms are predictive of higher mortality and more frequent exacerbations; therefore, they should be a target of therapy. During night-time, in COPD patients the supine position is responsible for a different thoracic physiology; moreover, during some sleep phases the vagal stimulation determines increased bronchial secretions, increased blood flow in the bronchial circulation (…

medicine.medical_specialtyCOPDEveningbusiness.industryGeneral MedicineDiseasemedicine.diseaseSleep medicinerespiratory tract diseases03 medical and health sciences0302 clinical medicinePharmacotherapy030228 respiratory systemBronchiolitisInternal medicinemedicine030212 general & internal medicinebusinessDynamic hyperinflationAsthmaInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct